Min Jun

About Associate Professor Min Jun

Program Lead

Min Jun is Scientia Associate Professor and Program Lead at the George Institute for Global Health, Faculty of Medicine, UNSW Sydney.

Min leads a program of research focused on understanding the impact of clinical management strategies in people with kidney disease and its related complications. He has developed and leads international projects using large clinical trial and real-world, population based data sources.

Min holds a PhD (2012) and MScMed(ClinEpi) in clinical epidemiology from the University of Sydney, and a MSc(by research) and BSc(Hon) from UNSW Sydney. He was previously an NHMRC Early Career Fellow (2013-2016) based in Canada (University of Calgary), co-funded by two additional competitive federal/provincial Canadian fellowships (CIHR/AIHS). Min's research track record includes >100 publications (including in top-ranked journals e.g. BMJ, Lancet, JACC), >$5.1M in research funding from top-level funding agencies (e.g. NHMRC). To date, 72% of his work is published in top 10% journals worldwide, has been cited >4500 times including in some 24 international clinical practice guidelines across various fields.

Min is actively involved in mentoring, training and supervising research students and fellows. He currently serves as Associate Editor (Global Health) for Kidney and Blood Pressure Research and has been involved in the development of clinical practice guidelines for the care of patients with kidney disease in Australia and internationally.

Embracing good practices of confirmatory studies

Kidney and Blood Pressure Research Date published:

Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial

American Journal of Nephrology Date published:

Caring for Australians and New Zealanders with kidney Impairment guidelines commentary on the Kidney Disease: Improving Global Outcomes clinical practice guideline for management of diabetes and chronic kidney disease

Internal Medicine Journal Date published:

SGLT2 inhibition in Patients with Type 2 Diabetes and CKD Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20ml/min/1.73m2

Journal of Cardiac Failure Date published:

Related Readings